Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sample size re-estimation in cluster randomization trials.

Stephen Lake1, Erin Kammann, Neil Klar

  • 1Department of Biostatistics, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA 02115, USA. slake@hsph.harvard.edu

Statistics in Medicine
|August 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Test-retest reliability of FreeSurfer measures of neurodegeneration.

NeuroImage·2026
Same author

Correction: Predictors for the use of systemic therapy in stage IB Mycosis fungoides.

Archives of dermatological research·2024
Same author

Predictors for the use of systemic therapy in stage IB Mycosis fungoides.

Archives of dermatological research·2024
Same author

The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people.

Immunity & ageing : I & A·2024
Same author

The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people.

Research square·2024
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

Cluster randomization trials for disease prevention interventions can improve sample size estimation. This method uses early data to refine estimates, ensuring studies remain adequately powered and practical.

Area of Science:

  • Biostatistics
  • Epidemiology
  • Public Health

Background:

  • Cluster randomization trials (CRTs) are frequently used for evaluating disease prevention interventions, with families as the unit of allocation.
  • Accurate estimation of nuisance parameters (within-cluster and between-cluster variability, cluster size variability) is crucial for sample size determination in CRTs.
  • Misspecification of these parameters can lead to underpowered studies, compromising the evaluation of interventions.

Purpose of the Study:

  • To propose and evaluate a flexible and practical method for sample size re-estimation in cluster randomization trials.
  • To extend internal pilot study methods to the specific context of cluster randomization trials.
  • To address the challenge of obtaining accurate advance estimates for nuisance parameters in CRTs.

Related Experiment Videos

Main Methods:

  • Utilizing a portion of the data collected over time to estimate nuisance parameters within the trial.
  • Re-estimating the required sample size based on these dynamically updated parameter estimates.
  • Employing simulation analyses to assess the impact of this design on statistical power, significance level, and overall sample size.

Main Results:

  • The proposed method demonstrated flexibility and practicality in managing sample size for cluster randomization trials.
  • Simulations indicated that this approach effectively adjusts for uncertainties in nuisance parameter estimation.
  • The design helps maintain adequate statistical power, even with initial misspecification of parameters.

Conclusions:

  • This adaptive sample size re-estimation strategy offers a robust solution for cluster randomization trials.
  • It enhances the reliability of power calculations and resource allocation in disease prevention research.
  • The method provides a practical framework for conducting more efficient and effective cluster randomized trials.